Synthesis, the antifungal and antibacterial activity of N1-substituted N2-(4,5-dihydro-1,3-thiazol-2-yl)glycinamides
DOI:
https://doi.org/10.24959/ophcj.17.924Keywords:
dihydroimidazo[2, 1-b][1, 3]thiazol, aminolysis, 2-thiazolylglycinamides, antifungal and antibacterial activityAbstract
Aim. To apply cleavage of 2-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-(6H)-one with morpholine and piperidine for preparation of the previously unknown N1-substituted N2-(4,5-dihydro-1,3-thiazol-2-il)glycineamides as promising compounds for further study of the antibacterial properties.
Results and discussion. It has been shown that the reaction of 2-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-(6H)-one with the primary and secondary amines can be effectively used for the synthesis of N1-substituted N2-(4,5-dihydro-1,3-thiazol-2-il)glycineamides. Some glycinamides obtained demonstrate the antifungal and antibacterial properties in the range of concentrations of 7.81-62.50 mkg/ml.
Experimental part. 2-Methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-(6H)-one reacts regioselectively with the primary and secondary amines in THF solution forming N1-substituted N2-(4,5-dihydro-1,3-thiazol-2-yl)glycineamides with the yields of 77-95%. Their structure has been proven by the complex spectral analysis. The screening of the antifungal and antibacterial properties of the compounds synthesized was conducted by the micromethod of double serial dilutions in the liquid nutritious medium.
Conclusions. It has been found that cleavage of 2-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-(6H)-one with the primary and secondary amines is a convenient method for the synthesis of N1-substituted N2-(4,5-dihydro-1,3-thiazol-2-il)glycineamides; among them substances with a marked antimicrobial activity have been found.
Downloads
References
- Das, D., Sikdar, P., Bairagi, M. (2012). Recent development of 2–aminothiasoles in medicinal chemistry. European Journal of Medicilal Chemistry, 109, 89–98. doi: 10.1016/j.ejmech.2015.12.022
- Bon, R. S., Buch, D. J. (2013). In pursuit of small molecules chemistry for calcium–permeable non–selective TRPC channels–mirage or pot of gold. British Journal of Pharmacology, 170 (3), 459–474. doi: 10.1111/bph.12274
- Pieroni, M., Wan, B., Cho, S. et al. (2014). Design, synthesis and investigation on the structure–activity relationships of N–substituted 2–aminothiazole derivatives as antitubercular agents. European Journal of Medicilal Chemistry, 72, 26–34. doi: 10.1016/j.ejmech.2013.11.007
- Merssner, A., Boskoft, H. I., Vasan, M. et al. (2013). Structure–activity relationships of 2–aminothiazoles effective against Mycobacterium tuberculosis. Bioorganic and Medicinal Chemistry, 21 (21), 6385–6397. doi: 10.1016/j.bmc.2013.08.048
- Pan, Yu., Li, P., Xie, S. et al. (2016). Synthesis, 3D–QSAR analysis and biological evaluation of quinoxoline 1,4–di–N–oxide derivatives as antituberculosis agent. Bioorganic and Medicinal Chemistry Letters, 26 (16), 4146–4153. doi: 10.1016/j.bmcl.2016.01.066
- Baruah, B., Dasa, K., Vaitiligam, B. et al. (2004). 1,2–Diaryl–1–ethanone and pyrazolo[3,4–c]quinoline–4–one as novel selective cyclooxogenase–2–inhibitors. Bioorganic and Medicinal Chemistry Letters, 14 (2), 445–448. doi: 10.1016/j.bmcl.2003.10.052
- Li, H–Q., Yang, J., Ma, S., Qiao, C. (2012). Structure–based design of rhodanine–based acylsulfonamide derivates as antagonists of the anti–apoptotic Bcl–2 protein. Bioorganic and Medicinal Chemistry, 20 (14), 4194–4200. doi: 10.1016/j.bmc.2012.05.079
- Li, S–N., Xu, Y–Y., Goo, J–Y. et al. (2015). Combination of 4–anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors. Bioorganic and Medicinal Chemistry, 23 (13), 3221–3227. doi: 10.1016/j.bmc.2015.04.065
- Coppola, B. P., Noe, M. C., Hong, S. S.–K. (1997). Regiocontrol in the 1,3–dipolar cycloaddition reactions of mesoionic compounds with acetylenic dipolarophiles. Tetrahedron Letters, 38 (41), 7159–7162. doi: 10.1016/s0040–4039(97)01761–9
- Imomoto, H., Iwanomi, T., Alnabane, M., Tani, Y. (2003). Substituted 1–aza–2–iminoheterocycles and their use as acetylholin receptors activators. Pat. US 134848; declared 21.11.2001; published 17.07.2003.
- Saliieva, L. M., Slyvka, N. Yu., Vaskevich, R. I., Vovk, M. V. (2016). Ukrainskii Khimicheskii Zhurnal, 5, 64–70.
- Alcaide, B., Plumet, J., Sierra, M. A. (1989). The reaction of α–diketones with primary heteroaromatic amines.Synthesis and reactions of imidazo[1, 2–a]pyridin–3(2H)–ones and N–heteroaryl α–iminoketones. Tetrahedron, 45 (21), 6841–6856. doi: 10.1016/s0040–4020(01)89152–3
- Towner, K. J., Grenwod, D. (2001) The problem of resistance. Antimicrobial chemotherapy. 4th/ed.Oxford,New York:OxfordUniversity Press, 131–144.
- Hecht, D.W. (2004). Prevalence of Antibiotic Resistance Anaerobic Bacteria: Worrisome Developments. Clinical Infections Diseases, 39 (1), 92–97. doi: 10.1086/421558
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).